Works matching AU Kolterman, Orville G.

Results: 26

Pramlintide reduces postprandial glucose excursions when added to regular insulin or insulin lispro in subjects with type 1 diabetes: a dose-timing study.

Published in:

2003

By:

Weyer, Christian;
Gottlieb, Alan;
Kim, Dennis D.;
Lutz, Karen;
Schwartz, Sherwyn;
Gutierrez, Maria;
Wang, Yan;
Ruggles, James A.;
Kolterman, Orville G.;
Maggs, David G.

Publication type:

journal article

Pramlintide as an adjunct to insulin therapy improves long-term glycemic and weight control in patients with type 2 diabetes: a 1-year randomized controlled trial.

Published in:

2003

By:

Hollander, Priscilla A.;
Levy, Philip;
Fineman, Mark S.;
Maggs, David G.;
Shen, Larry Z.;
Strobel, Susan A.;
Weyer, Christian;
Kolterman, Orville G.

Publication type:

journal article

Impact of pramlintide on glucose fluctuations and postprandial glucose, glucagon, and triglyceride excursions among patients with type 1 diabetes intensively treated with insulin pumps.

Published in:

2003

By:

Levetan, Claresa;
Want, Laura L.;
Weyer, Christian;
Strobel, Susan A.;
Crean, John;
Wang, Yan;
Maggs, David G.;
Kolterman, Orville G.;
Chandran, Manju;
Mudaliar, Sunder R.;
Henry, Robert R.

Publication type:

journal article

A Randomized Study and Open-Label Extension Evaluating the Long-Term Efficacy of Pramlintide as an Adjunct to Insulin Therapy in Type 1 Diabetes.

Published in:

Diabetes Care, 2002, v. 25, n. 4, p. 724, doi. 10.2337/diacare.25.4.724

By:

Whitehouse, Fred;
Kruger, Davida F.;
Fineman, Mark;
Shen, Larry;
Ruggles, James A.;
Maggs, David G.;
Weyer, Christian;
Kolterman, Orville G.

Publication type:

Article

Pramlintide, a synthetic analog of human amylin, improves the metabolic profile of patients with type 2 diabetes using insulin. The Pramlintide in Type 2 Diabetes Group.

Published in:

1998

By:

Thompson, Robert G.;
Pearson, Leeanne;
Schoenfeld, Steven K.;
Kolterman, Orville G.;
Thompson, R G;
Pearson, L;
Schoenfeld, S L;
Kolterman, O G

Publication type:

journal article

Empirical Validation for a Family-Centered Model of Care.

Published in:

Diabetes Care, 1995, v. 18, n. 10, p. 1347, doi. 10.2337/diacare.18.10.1347

By:

Hanson, Cindy L.;
De Guire, Michelle J.;
Schinkel, Angle M.;
Kolterman, Orville G.

Publication type:

Article

Reduction of postprandial hyperglycemia in subjects with IDDM by intravenous infusion of AC137, a human amylin analogue.

Published in:

1995

By:

Kolterman, Orville G.;
Gottlieb, Alan;
Moyses, Chris;
Colburn, Wayne;
Kolterman, O G;
Gottlieb, A;
Moyses, C;
Colburn, W

Publication type:

journal article

Synthetic Exendin-4 (Exenatide) Significantly Reduces Postprandial and Fasting Plasma Glucose in Subjects with Type 2 Diabetes.

Published in:

Journal of Clinical Endocrinology & Metabolism, 2003, v. 88, n. 7, p. 3082, doi. 10.1210/jc.2002-021545

By:

KOLTERMAN, ORVILLE G.;
BUSE, JOHN B.;
FINEMAN, MARK S.;
GAINES, ELING;
HEINTZ, SONJA;
BICSAK, THOMAS A.;
TAYLOR, KRISTIN;
KIM, DENNIS;
AISPORNA, MARIA;
YAN WANG;
BARON, ALAIN D.

Publication type:

Article

Properties of pramlintide and insulin upon mixing.

Published in:

American Journal of Health-System Pharmacy, 2005, v. 62, n. 8, p. 816, doi. 10.1093/ajhp/62.8.816

By:

Weyer, Christian;
Fineman, Mark S.;
Strobel, Susan;
Shen, Larry;
Data, Joann;
Kolterman, Orville G.;
Sylvestri, Mario F.

Publication type:

Article

Pharmacokinetics, pharmacodynamics, and safety of exenatide in patients with type 2 diabetes mellitus.

Published in:

American Journal of Health-System Pharmacy, 2005, v. 62, n. 2, p. 173., doi. 10.1093/ajhp/62.2.173

By:

Kolterman, Orville G.;
Kim, Dennis D.;
Shen, Larry;
Ruggles, James A.;
Nielsen, Loretta L.;
Fineman, Mark S.;
Baron, Alain D.

Publication type:

Article

Effect of Pramlintide on Weight in Overweight and Obese Insulin-Treated Type 2 Diabetes Patients<sup>**</sup>.

Published in:

Obesity (19307381), 2004, v. 12, n. 4, p. 661, doi. 10.1038/oby.2004.76

By:

Hollander, Priscilla;
Maggs, David G.;
Ruggles, James A.;
Fineman, Mark;
Shen, Larry;
Kolterman, Orville G.;
Weyer, Christian

Publication type:

Article

Pramlintide reduces postprandial glucose excursions when added to insulin lispro in subjects with type 2 diabetes: a dose-timing study.

Published in:

Diabetes/Metabolism Research & Reviews, 2004, v. 20, n. 1, p. 55, doi. 10.1002/dmrr.419

By:

David G. Maggs;
Mark Fineman;
Jonathan Kornstein;
Terrie Burrell;
Sherwyn Schwartz;
Yan Wang;
James A. Ruggles;
Orville G. Kolterman;
Christian Weyer

Publication type:

Article

Pharmacokinetics and Pharmacodynamics of AC137 (25,28,29 Tripro-Amylin, Human) After Intravenous Bolus and Infusion Doses in Patients with Insulin-Dependent Diabetes.

Published in:

1996

By:

Colburn, Wayne A.;
Gottlieb, Alan B.;
Koda, Joy;
Kolterman, Orville G.

Publication type:

Other

Pramlintide improved measures of glycemic control and body weight in patients With type 1 diabetes mellitus undergoing continuous subcutaneous insulin infusion therapy.

Published in:

2013

By:

Herrmann, Kathrin;
Frias, Juan P;
Edelman, Steven V;
Lutz, Karen;
Shan, Kevin;
Chen, Steven;
Maggs, David;
Kolterman, Orville G

Publication type:

Journal Article

Metabolic consequence of two-week fructose feeding in diabetic subjects.

Published in:

1986

By:

CRAPO, PHYLLIS A.;
KOLTERMAN, ORVILLE G.;
HENRY, ROBERT R.;
Crapo, P A;
Kolterman, O G;
Henry, R R

Publication type:

journal article

The Impact of Sulfonylurea Treatment upon the Mechanisms Responsible for the Insulin Resistance in Type II Diabetes.

Published in:

Diabetes Care, 1984, v. 7, p. 81

By:

Kolterman, Orville G.;
Olefsky, Jerrold M.

Publication type:

Article

The effects of oral fructose, sucrose, and glucose in subjects with reactive hypoglycemia.

Published in:

1982

By:

Crapo, Phyllis A.;
Scarlett, John A.;
Kolterman, Orville G.;
Sanders, Leonard R.;
Hofeldt, Fred D.;
Olefsky, Jerrold M.;
Crapo, P A;
Scarlett, J A;
Kolterman, O G;
Sanders, L R;
Hofeldt, F D;
Olefsky, J M

Publication type:

journal article

Effects of oral fructose in normal, diabetic, and impaired glucose tolerance subjects.

Published in:

1980

By:

CRAPO, PHYLLIS A.;
KOLTERMAN, ORVILLE G.;
OLEFSKY, JERROLD M.;
Crapo, P A;
Kolterman, O G;
Olefsky, J M

Publication type:

journal article

41-LB: Changes in Circulating Metabolites, Including Butyrate, Points to Underlying Mechanism of a Probiotic Intervention That Improves Postprandial Hyperglycemia in Subjects with Type 2 Diabetes.

Published in:

Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-41-LB

By:

MCMURDIE, PAUL;
STOEVA, MAGDALENA K.;
NEMCHEK, MADELEINE;
TYAGI, SURABHI;
GINES, JESSICA;
EID, JOHN;
KOLTERMAN, ORVILLE G.

Publication type:

Article

135-OR: A Novel Thiazolidinedione (TZD) with Minimal PPAR-γ Activity Maximized for Mitochondrial Pyruvate Carrier (MPC) Modulation: Six-Month Analysis of Glycemia in a 12-Month Nonalcoholic Steatohepatitis (NASH) Study.

Published in:

Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-135-OR

By:

CUSI, KENNETH;
KOLTERMAN, ORVILLE G.;
HARRISON, STEPHEN A.;
DITTRICH, HOWARD C.

Publication type:

Article

758-P: Medical Food (MF) with Butyrate Producing (BP)+Mucin Regulating (MR) Microbes Improves Glucose Control (GC) in T2D.

Published in:

Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-758-P

By:

KOLTERMAN, ORVILLE G.;
PERRAUDEAU, FANNY;
IYER, MOHAN S.;
EID, JOHN S.;
BULLARD, JAMES;
SCHICKLBERGER, MARCUS F.;
CHENG, ANDREW;
JUSTICE, NICHOLAS;
MCMURDIE, PAUL;
STONEBURNER, BRENDON;
GINES, JESSICA;
TYAGI, SURABHI;
CUTCLIFFE, COLLEEN

Publication type:

Article

2046-P: NS-0200 (Leucine-Metformin-Sildenafil) Reduces Weight in Obese Subjects: A 24-Week Randomized Trial.

Published in:

Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-2046-P

By:

ZEMEL, MICHAEL B.;
KOLTERMAN, ORVILLE G.;
FLORES, OMAR;
FLEMING, GILBERT ALEXANDER;
GREENWAY, FRANK L.

Publication type:

Article

Day-long integrated serum insulin and C-peptide profiles in patients with NIDDM. Correlation with urinary C-peptide excretion.

Published in:

1988

By:

Garvey, W. Timothy;
Olefsky, Jerrold M.;
Rubenstein, Arthur H.;
Kolterman, Orville G.;
Garvey, W T;
Olefsky, J M;
Rubenstein, A H;
Kolterman, O G

Publication type:

journal article

Decreased activation of skeletal muscle glycogen synthase by mixed-meal ingestion in NIDDM.

Published in:

1988

By:

Wright, Kimberly S.;
Beck-Nielsen, Henning;
Kolterman, Orville G.;
Mandarino, Lawrence J.;
Wright, K S;
Beck-Nielsen, H;
Kolterman, O G;
Mandarino, L J

Publication type:

journal article

Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetics.

Published in:

1987

By:

Baron, Alain D.;
Schaeffer, Linda;
Shragg, Paul;
Kolterman, Orville G.;
Baron, A D;
Schaeffer, L;
Shragg, P;
Kolterman, O G

Publication type:

journal article

Relationship between serum glucose level and the metabolic clearance rate of glucose in non-insulin-dependent diabetes mellitus.

Published in:

1983

By:

Revers, Robert R.;
Kolterman, Orville G.;
Olefsky, Jerrold M.;
Revers, R R;
Kolterman, O G;
Olefsky, J M

Publication type:

journal article